克拉斯G12C和G12D驱动的肺癌在瘤性强度,免疫性和在小鼠模型中克拉斯抑制后复发方面存在差异
Hai-Cheng Huang1,2, Qing Deng1,2, Lei Guo3
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Science translational medicine
|February 4, 2026
概括
克拉斯G12D突变导致比G12C更具攻击性的肺癌. 抑制KRAS G12D可以增强免疫反应,为非小细胞肺癌 (NSCLC) 提供潜在的组合疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- KRAS突变是非小细胞肺癌 (NSCLC) 的常见驱动因素.
- 在KRAS G12D和KRAS G12C突变之间存在不同的生物行为.
- 了解这些差异对于开发有针对性的疗法至关重要.
研究的目的:
- 为了比较NSCLC中KRAS G12D和G12C突变的瘤生物学.
- 研究KRAS G12D抑制的机制和强化策略.
- 为了评估与免疫检查点封锁的组合疗法.
主要方法:
- 利用了NSCLC的基因工程小鼠模型 (GEMMs).
- 分析了患者的瘤样本.
- 给药的基因基因特异性KRAS抑制剂和免疫检查点阻塞.
主要成果:
- 克拉斯G12D驱动的瘤呈现出比G12C驱动的瘤更快的进展和复发.
- G12C瘤的生长速度较慢,免疫细胞透率增加.
- 抑制KRAS G12D可以增强抗原呈现和T细胞激活,从而提高免疫原模型中组合疗法的疗效.
结论:
- 克拉斯G12D和G12C突变赋予了不同的瘤生物学和抵抗力学.
- 抑制KRAS G12D可以与免疫疗法协同作用,在特定情况下诱导免疫记忆.
- 这些发现为NSCLC治疗策略提供了翻译性见解.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Feedback Inhibition
57.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Source And Potency Of Stem Cells
6.3K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
6.3K
Enzyme Inhibition
92.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.5K


